Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMGCR | P04035 | 1/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.50 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | CPT2 | P23786 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.34 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.32 |
| ▸ | ACLY | P53396 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17687579 | 0.82 | HMGCR (0.35) | HMGCRCHRM1TBXA2RADRA1AKDM4E | |
| Hydrochloric Acid SCHEMBL4137653 | 0.77 | TSHR (0.60) | HMGCRCHRM1TBXA2RADRA1AKDM4E | |
| SCHEMBL83915 | 0.77 | TSHR (0.60) | HMGCRCHRM1TBXA2RADRA1AKDM4E | |
| SCHEMBL126425 | 0.76 | HMGCR (0.55) | HMGCRCHRM1TBXA2RADRA1AKDM4E | |
| SCHEMBL9314915 | 0.75 | FAAH (0.35) | HMGCRCHRM1TBXA2RADRA1ATSHR | |
| SCHEMBL30703619 | 0.75 | TSHR (0.42) | HMGCRCHRM1TBXA2RADRA1AKDM4E | |
| SCHEMBL166880 | 0.74 | TSHR (0.40) | HMGCRCHRM1TBXA2RADRA1ATSHR | |
| SCHEMBL392087 | 0.74 | TSHR (0.40) | HMGCRCHRM1TBXA2RADRA1ATSHR | |
| SCHEMBL8844260 | 0.74 | TSHR (0.57) | HMGCRCHRM1TBXA2RADRA1AKDM4E | |
| Ammonia Solution, Strong SCHEMBL10868076 | 0.74 | TSHR (0.57) | HMGCRCHRM1TBXA2RADRA1AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 181 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3796922-B1 | PHARMACEUTICAL COMPOSITIONS COMPRISING A SELENO AMINO ACID COMPOUND FOR USE IN COMBINATION WITH ANOTHER AGENT FOR THE TREATMENT OF LIVER OR PANCREAS CANCER | SELEQ OY (FI) | 2026-03-18 | — | — | EP | claimed |
| US-12310936-B2 | Pharmaceutical compositions for the treatment of cancer | SELEQ OY (FI) | 2025-05-27 | — | — | US | claimed |
| US-20250136932-A1 | COMPOSITIONS AND METHODS FOR CULTURING AND MAINTAINING TROPHOBLAST STEM CELLS | NORTH CAROLINA STATE UNIVERSITY | 2025-05-01 | — | — | US | claimed |
| WO-2023147001-A1 | COMPOSITIONS AND METHODS FOR CULTURING AND MAINTAINING TROPHOBLAST STEM CELLS | NORTH CAROLINA STATE UNIVERSITY (US) | 2023-08-03 | — | — | WO | claimed |
| EP-3218010-B1 | POLYMER COMPOSED OF REPEAT UNITS HAVING A BIOLOGICALLY ACTIVE MOLECULE ATTACHED THERETO VIA A PH-SENSITIVE BOND | SPIREA LTD (GB) | 2022-10-26 | — | — | EP | claimed |
| US-20210220310-A1 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER | SELEQ OY (FI) | 2021-07-22 | — | — | US | claimed |
| US-11020408-B2 | Polymer composed of repeat units having a biologically active molecule attached thereto via a pH-sensitive bond | SPIREA LIMITED (GB) | 2021-06-01 | — | — | US | claimed |
| EP-3796922-A1 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER | Seleq Oy (FI) | 2021-03-31 | — | — | EP | claimed |
| WO-2020209059-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING HYPERAMMONEMIA | 学校法人 久留米大学 | 2020-10-15 | — | — | WO | claimed |
| US-20200289531-A1 | POLYMER COMPOSED OF REPEAT UNITS HAVING A BIOLOGICALLY ACTIVE MOLECULE ATTACHED THERETO VIA A PH-SENSITIVE BOND | SPIREA LIMITED (GB) | 2020-09-17 | — | — | US | claimed |
| US-10709717-B2 | Polymer composed of repeat units having a biologically active molecule attached thereto via a pH-sensitive bond | SPIREA LIMITED (GB) | 2020-07-14 | — | — | US | claimed |
| EP-3218010-A1 | POLYMER COMPOSED OF REPEAT UNITS HAVING A BIOLOGICALLY ACTIVE MOLECULE ATTACHED THERETO VIA A PH-SENSITIVE BOND | Spirea Limited (GB) | 2017-09-20 | — | — | EP | claimed |
| US-20170224828-A1 | POLYMER COMPOSED OF REPEAT UNITS HAVING A BIOLOGICALLY ACTIVE MOLECULE ATTACHED THERETO VIA A PH-SENSITIVE BOND | SPIREA LIMITED (GB) | 2017-08-10 | — | — | US | claimed |
| WO-2016059391-A1 | POLYMER COMPOSED OF REPEAT UNITS HAVING A BIOLOGICALLY ACTIVE MOLECULE ATTACHED THERETO VIA A PH-SENSITIVE BOND | OUBERAI MYRIAM MARIE (GB) | 2016-04-21 | — | — | WO | claimed |
| EP-0219923-B1 | ANTIBIOTIC DERIVATIVES, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1992-09-02 | — | — | EP | claimed |
| EP-3796922-B1 | PHARMACEUTICAL COMPOSITIONS COMPRISING A SELENO AMINO ACID COMPOUND FOR USE IN COMBINATION WITH ANOTHER AGENT FOR THE TREATMENT OF LIVER OR PANCREAS CANCER | SELEQ OY (FI) | 2026-03-18 | — | — | EP | disclosed |
| US-20250367157-A1 | COMPOSITION FOR USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH DYSFUNCTION OF MITOCHONDRIAE | IUF LEIBNIZ INST FUER UMWELTMEDIZINISCHE FORSCHUNG GMBH (DE) | 2025-12-04 | — | — | US | disclosed |
| EP-0219923-B1 | ANTIBIOTIC DERIVATIVES, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1992-09-02 | — | — | EP | disclosed |
| US-4851422-A | Antibiotic 2-(3-oxo-2-isoxazolidinyl)-5-oxo-2-tetrahydrofuran-carboxylates | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1989-07-25 | — | — | US | disclosed |
| EP-0219923-A1 | Antibiotic derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1987-04-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11020408-B2 | Polymer composed of repeat units having a biologically active molecule attached thereto via a pH-sensitive bond | IL1R1, SRRM2, H1-2 | HMGCR 680/4885CHRM1 1044/4885TBXA2R 1562/4885 |
| US-20170224828-A1 | POLYMER COMPOSED OF REPEAT UNITS HAVING A BIOLOGICALLY ACTIVE MOLECULE ATTACHED THERETO VIA A PH-SENSITIVE BOND | IL1R1, SRRM2, H1-2 | HMGCR 680/4885CHRM1 1044/4885TBXA2R 1562/4885 |
| US-20210220310-A1 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER | RNASE1, SELENOI, GLS2 | HMGCR 1075/4885CHRM1 4843/4885TBXA2R 3431/4885 |
| US-20200289531-A1 | POLYMER COMPOSED OF REPEAT UNITS HAVING A BIOLOGICALLY ACTIVE MOLECULE ATTACHED THERETO VIA A PH-SENSITIVE BOND | IL1R1, SRRM2, H1-2 | HMGCR 680/4885CHRM1 1044/4885TBXA2R 1562/4885 |
| US-10709717-B2 | Polymer composed of repeat units having a biologically active molecule attached thereto via a pH-sensitive bond | IL1R1, SRRM2, H1-2 | HMGCR 680/4885CHRM1 1044/4885TBXA2R 1562/4885 |
| US-12310936-B2 | Pharmaceutical compositions for the treatment of cancer | RNASE1, SELENOI, GLS2 | HMGCR 1075/4885CHRM1 4843/4885TBXA2R 3431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.